EdgarLookup

NewtekOne, Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that NewtekOne, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
2.2%
Return on Assets
Net income ÷ assets
5.9x
Debt-to-Equity
Total liabilities ÷ equity

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $60.51M Mar 10, 2026
FY2025 Dec 31, 2024 $50.85M Mar 10, 2026
FY2025 Dec 31, 2023 $47.33M Mar 10, 2026
FY2023 Sep 30, 2023 $10.92M Apr 1, 2024
FY2023 Jun 30, 2023 $7.01M Apr 1, 2024
FY2023 Mar 31, 2023 $18.55M Apr 1, 2024
FY2024 Dec 31, 2022 $32.31M Mar 17, 2025
FY2023 Mar 31, 2022 $9.65M May 11, 2023
FY2023 Dec 31, 2021 $84.14M Apr 1, 2024

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($579.24M) Mar 10, 2026
FY2025 Dec 31, 2024 ($153.01M) Mar 10, 2026
FY2025 Dec 31, 2023 ($169.22M) Mar 10, 2026
FY2023 Mar 31, 2023 ($116.36M) May 11, 2023
FY2024 Dec 31, 2022 ($62.42M) Mar 17, 2025
FY2023 Mar 31, 2022 $6.48M May 11, 2023
FY2023 Dec 31, 2021 $140.92M Apr 1, 2024

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $106.0K Mar 10, 2026
FY2025 Dec 31, 2024 $439.0K Mar 10, 2026
FY2025 Dec 31, 2023 $458.0K Mar 10, 2026
FY2023 Mar 31, 2023 $165.0K May 11, 2023
FY2024 Dec 31, 2022 $11.0K Mar 17, 2025
FY2023 Mar 31, 2022 $0 May 11, 2023
FY2023 Dec 31, 2021 $0 Apr 1, 2024

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.74B Mar 10, 2026
FY2025 Dec 31, 2024 $2.06B Mar 10, 2026
FY2025 Dec 31, 2023 $1.43B Mar 10, 2026
FY2023 Sep 30, 2023 $1.39B Apr 1, 2024
FY2023 Jun 30, 2023 $1.45B Apr 1, 2024
FY2023 Mar 31, 2023 $1.26B Apr 1, 2024
FY2023 Dec 31, 2022 $998.90M Apr 1, 2024

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.35B Mar 10, 2026
FY2025 Dec 31, 2024 $1.76B Mar 10, 2026
FY2024 Dec 31, 2023 $1.18B Mar 17, 2025
FY2023 Sep 30, 2023 $1.15B Apr 1, 2024
FY2023 Jun 30, 2023 $1.22B Apr 1, 2024
FY2023 Mar 31, 2023 $1.03B Apr 1, 2024
FY2023 Dec 31, 2022 $623.54M Apr 1, 2024

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $397.57M Mar 10, 2026
FY2025 Dec 31, 2024 $296.28M Mar 10, 2026
FY2025 Dec 31, 2023 $249.05M Mar 10, 2026
FY2023 Sep 30, 2023 $242.20M Apr 1, 2024
FY2023 Jun 30, 2023 $235.45M Apr 1, 2024
FY2023 Mar 31, 2023 $232.59M Apr 1, 2024
FY2024 Dec 31, 2022 $375.36M Mar 17, 2025
FY2024 Dec 31, 2021 $403.89M Mar 17, 2025

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $14.09M Mar 10, 2026
FY2025 Dec 31, 2024 $14.09M Mar 10, 2026
FY2024 Dec 31, 2023 $25.89M Mar 17, 2025
FY2023 Mar 31, 2023 $21.19M May 11, 2023
FY2023 Dec 31, 2022 $0 Apr 1, 2024

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $94.99M Mar 10, 2026
FY2025 Dec 31, 2024 $57.77M Mar 10, 2026
FY2024 Dec 31, 2023 $28.05M Mar 17, 2025
FY2023 Sep 30, 2023 $22.20M Apr 1, 2024
FY2023 Jun 30, 2023 $16.07M Apr 1, 2024
FY2023 Mar 31, 2023 $13.88M Apr 1, 2024
FY2023 Dec 31, 2022 $20.62M Apr 1, 2024

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $819.89M Mar 10, 2026
FY2025 Dec 31, 2024 $708.04M Mar 10, 2026
FY2024 Dec 31, 2023 $644.12M Mar 17, 2025
FY2023 Mar 31, 2023 $697.40M May 11, 2023
FY2023 Dec 31, 2022 $539.33M Apr 1, 2024

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 2 Mar 10, 2026
FY2025 Dec 31, 2024 1 Mar 10, 2026
FY2025 Dec 31, 2023 1 Mar 10, 2026
FY2023 Sep 30, 2023 0 Apr 1, 2024
FY2023 Jun 30, 2023 0 Apr 1, 2024
FY2023 Mar 31, 2023 0 Apr 1, 2024
FY2024 Dec 31, 2022 1 Mar 17, 2025
FY2023 Mar 31, 2022 0 May 11, 2023
FY2023 Dec 31, 2021 3 Apr 1, 2024

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 2 Mar 10, 2026
FY2025 Dec 31, 2024 1 Mar 10, 2026
FY2025 Dec 31, 2023 1 Mar 10, 2026
FY2023 Sep 30, 2023 0 Apr 1, 2024
FY2023 Jun 30, 2023 0 Apr 1, 2024
FY2023 Mar 31, 2023 0 Apr 1, 2024
FY2024 Dec 31, 2022 1 Mar 17, 2025
FY2023 Mar 31, 2022 0 May 11, 2023
FY2023 Dec 31, 2021 3 Apr 1, 2024

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 28.66M Mar 10, 2026
FY2025 Dec 31, 2024 26.29M Mar 10, 2026
FY2024 Dec 31, 2023 24.68M Mar 17, 2025
FY2023 Mar 31, 2023 24.61M May 11, 2023
FY2023 Dec 31, 2022 24.61M Apr 1, 2024